ReviewCureus2025
Exploring Risk Factors and Patterns in Uncommon Recurrences of Varicella-Zoster Reactivation: A Review of Case Reports.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Varicella-zoster virus (VZV) causes chickenpox and then establishes latency in the autonomic ganglia. Reactivation of the virus, known as herpes zoster or shingles, manifests as a unilateral, vesicular rash localized within one dermatome accompanied by pain and pruritus. While the classic rash resolves within three weeks, older or immunocompromised individuals may experience prolonged symptoms, increased vesicle number, and complications such as post-herpetic neuralgia. Although the classic manifestations of VZV are well known, more cases are appearing with an atypical presentation. We highlight eight reports of unusual presentations describing confirmed cases of VZV that become reactivated and note a wide range of ages, with half over 70 years of age and half under 40 years of age, two including children. Unusual presentations include zoster sine herpete, vocal fold paralysis due to vagal nerve involvement, and encephalitis with massive pulmonary emboli in a previously healthy 37-year-old woman. One case features a child who developed shingles from the vaccine strain of VZV. Diagnostic delays occurred in all cases due to the atypical nature of the presentations, often resulting in initial misdiagnoses and inappropriate treatments such as antibiotics or corticosteroids. Despite eventual antiviral therapy, two patients experienced incomplete recovery, suffering from persistent neuropathic pain or muscle atrophy. These cases emphasize the variability in VZV presentations, the importance of timely diagnosis, and the need for greater clinical awareness to prevent delayed treatment and adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.